6:05 PM
 | 
Oct 22, 2008
 |  BC Extra  |  Company News

Antigenics submits MAA for Oncophage

Antigenics (NASDAQ:AGEN) submitted an MAA to EMEA for conditional...

Read the full 29 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >